Literature DB >> 7726828

Human peripheral eosinophils have a specific mechanism to express gp91-phox, the large subunit of cytochrome b558.

F Kuribayashi1, A Kumatori, S Suzuki, M Nakamura, T Matsumoto, Y Tsuji.   

Abstract

Eosinophils as well as neutrophils, monocytes and B lymphocytes are noted for lacking normal cytochrome b558 in patients with X-linked chronic granulomatous disease. The eosinophils of an X-linked male patient, however, fully expressed surface cytochrome b558, generated superoxide anion to a normal extent and definitely expressed the large subunit of cytochrome b558 (gp91-phox). His mononuclear leukocytes contained a diminished amount of gp91-phox mRNA with normal coding sequences. All the coding sequences and a putative poly (A) signal of his gp91-phox gene were normal. These results indicate that eosinophils have a specific mechanism to express gp91-phox and suggest that the mechanism lies at the transcriptional step of the gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7726828     DOI: 10.1006/bbrc.1995.1482

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  Hematologically important mutations: X-linked chronic granulomatous disease (third update).

Authors:  Dirk Roos; Douglas B Kuhns; Anne Maddalena; Joachim Roesler; Juan Alvaro Lopez; Tadashi Ariga; Tadej Avcin; Martin de Boer; Jacinta Bustamante; Antonio Condino-Neto; Gigliola Di Matteo; Jianxin He; Harry R Hill; Steven M Holland; Caroline Kannengiesser; M Yavuz Köker; Irina Kondratenko; Karin van Leeuwen; Harry L Malech; László Marodi; Hiroyuki Nunoi; Marie-José Stasia; Anna Maria Ventura; Carl T Witwer; Baruch Wolach; John I Gallin
Journal:  Blood Cells Mol Dis       Date:  2010-08-21       Impact factor: 3.039

2.  PU.1 as an essential activator for the expression of gp91(phox) gene in human peripheral neutrophils, monocytes, and B lymphocytes.

Authors:  S Suzuki; A Kumatori; I A Haagen; Y Fujii; M A Sadat; H L Jun; Y Tsuji; D Roos; M Nakamura
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

3.  Point mutations in the promoter region of the CYBB gene leading to mild chronic granulomatous disease.

Authors:  R S Weening; M De Boer; T W Kuijpers; V M Neefjes; W W Hack; D Roos
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

4.  A highly sensitive chemiluminescence assay for superoxide detection and chronic granulomatous disease diagnosis.

Authors:  Tsuyoshi Yamazaki; Chikage Kawai; Akira Yamauchi; Futoshi Kuribayashi
Journal:  Trop Med Health       Date:  2011-06-14

Review 5.  Genetics and immunopathology of chronic granulomatous disease.

Authors:  Marie José Stasia; Xing Jun Li
Journal:  Semin Immunopathol       Date:  2008-05-29       Impact factor: 11.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.